Cited by 1,331HIV-related health complications and treatmentsHIV/AIDS Research and InterventionsHIV Research and Treatment

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

. Premature Age-Related Comorbidities Among HIV-Infected Persons Compared with the General Population.

Guaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., Palella, F.·2011·Clinical Infectious Diseases

DOI 10.1093/cid/cir627

Open this paper in CoChat — free account

Abstract

BACKGROUND: Human immunodeficiency virus (HIV)-infected patients may have a greater risk of noninfectious comorbidities (NICMs) compared with the general population. We assessed the prevalence and risk factors for NICMs in a large cohort of HIV-infected adults and compared these findings with data from matched control subjects. METHODS: We performed a case-control study involving antiretroviral therapy (ART)-experienced HIV-infected patients treated at Modena University, Italy, from 2002 through 2009. These patients were compared with age-, sex-, and race-matched adults (control subjects) from the general population included in the CINECA ARNO database. NICMs included cardiovascular disease, hypertension, diabetes mellitus, bone fractures, and renal failure. Polypathology (Pp) was defined as the concurrent presence of ≥2 NICMs. Logistic regression models were constructed to evaluate associated predictors of NICMs and Pp. RESULTS: There were 2854 patients and 8562 control subjects. The mean age was 46 years, and 37% were women. Individual NICM and Pp prevalences in each age stratum were higher among patients than among controls (all P <.001). Pp prevalence among patients aged 41-50 years was similar to that among controls aged 51-60 years (P value was not statistically significant); diabetes mellitus, cardiovascular disease, bone fractures, and renal failure were statistically independent after adjustment for sex, age, and hypertension. Logistic regression models showed that independent predictors of Pp in the overall cohort were (all P < .001) age (odds ratio [OR], 1.11), male sex (OR, 1.77), nadir CD4 cell count <200 cells/μL (OR, 4.46), and ART exposure (OR, 1.01). CONCLUSIONS: Specific age-related NICMs and Pp were more common among HIV-infected patients than in the general population. The prevalence of Pp in HIV-infected persons anticipated Pp prevalence observed in the general population among persons who were 10 years older, and HIV-specific cofactors (lower nadir CD4 cell count and more prolonged ART exposure) were identified as risk factors. These data support the need for earlier screening for NICMs in HIV-infected patients.

Integrity signals

Registry

Crossref · 10.1093/cid/cir627

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Self-citation
CD4+ Count–Guided Interruption of Antiretroviral Treatment
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,250
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
(2008) · The Lancet · doi:10.1016/s0140-6736(08)61113-7 · Cited by 1,661
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Mortality in the Highly Active Antiretroviral Therapy Era
Palella, F. J., Baker, R. K., Moorman, A. C., Chmiel, J. S., Wood, K. C., Brooks, J. T., & Holmberg, S. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000233310.90484.16 · Cited by 1,362
Self-citation
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus
The Data Collection on Adverse Events of Anti-HIV Drugs Study Group* (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,115
Introduction to Graphical Modelling
Edwards, D. (2000) · Springer texts in statistics · doi:10.1007/978-1-4612-0493-0 · Cited by 809
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704

Flagged first, then by citations

Show all 31 references

1 of the 31 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Deeks, 2009, Topics in HIV medicine : a publication of the International AIDS Society, USA, 17, 118
Justice, 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA, 14, 159
2008, Annals of nutrition & metabolism, 52, 6, 10.1159/000115340 · DOI
2010, Research initiative, treatment action : RITA, 15, 29

Sorted by citations

Future challenges for clinical care of an ageing population infected with HIV: a modelling study
Smit, M., Brinkman, K., Geerlings, S. E., Smit, C., Thyagarajan, K., van Sighem, A., de Wolf, F., & Hallett, T. B. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00056-0 · Cited by 943
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
Schouten, J., Wit, F. W. N. M., Stolte, I. G., Kootstra, N. A., van der Valk, M., Geerlings, S. E., Prins, M., Reiss, P., for the AGEhIV Cohort Study Group, Reiss, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu701 · Cited by 773
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
Serrano-Villar, S., Sainz, T., Lee, S. A., Hunt, P. W., Sinclair, E., Shacklett, B. L., Ferre, A. L., Hayes, T. L., Somsouk, M., Hsue, P. Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004078 · Cited by 611
HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group
High, K. P., Brennan-Ing, M., Clifford, D. B., Cohen, M. H., Currier, J., Deeks, S. G., Deren, S., Effros, R. B., Gebo, K., Goronzy, J. J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825a3668 · Cited by 522
Microbial translocation in HIV infection: causes, consequences and treatment opportunities
Utay, N. S., & Douek, D. C. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2848 · Cited by 486
Is HIV a Model of Accelerated or Accentuated Aging?
Pathai, S., Bajillan, H., LANDAY, A. L., & High, K. P. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt168 · Cited by 437
Current status and prospects of HIV treatment
Cihlář, T., & Fordyce, M. W. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 352
Co-Morbidities in Persons Infected with HIV: Increased Burden with Older Age and Negative Effects on Health-Related Quality of Life
Rodriguez-Penney, A. T., Iudicello, J. E., Riggs, P. K., Doyle, K. L., Ellis, R. J., Letendre, S. L., Grant, I., & Woods, A. T. H. N. S. P. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0329 · Cited by 323
HIV
Ghosn, J., Taiwo, B., Seedat, S., Autran, B., & Katlama, C. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31311-4 · Cited by 332
Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA
Gross, A. M., Jaeger, P. A., Kreisberg, J. F., Licon, K., Jepsen, K., Khosroheidari, M., Morsey, B., Swindells, S., Shen, H., Ng, C. T., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.03.019 · Cited by 306
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions
Williams, E. C., Hahn, J. A., Saitz, R., Bryant, K., Lira, M. C., & Samet, J. H. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13204 · Cited by 294
Astrocyte senescence: Evidence and significance
Cohen, J., & Torres, C. (2019) · Aging Cell · doi:10.1111/acel.12937 · Cited by 281
HIV infection
Bekker, L., Beyrer, C., Mgodi, N. M., Lewin, S. R., Delany‐Moretlwe, S., Taiwo, B., Masters, M. C., & Lazarus, J. V. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00452-3 · Cited by 289
Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol
O’Brien, K. K., Tynan, A., Nixon, S., & Glazier, R. H. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1478-2 · Cited by 257
Comorbidities Among US Patients With Prevalent HIV Infection—A Trend Analysis
Gallant, J. E., Hsue, P. Y., Shreay, S., & Meyer, N. M. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix518 · Cited by 220
Increased brain-predicted aging in treated HIV disease
Cole, J. H., Underwood, J., Caan, M. W. A., Francesco, D. D., van Zoest, R. A., Leech, R., Wit, F. W. N. M., Portegies, P., Geurtsen, G. J., Schmand, B. A., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003790 · Cited by 219
Self-citation
Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010
Hernandez-Romieu, A. C., Garg, S., Rosenberg, E. S., Thompson-Paul, A. M., & Skarbinski, J. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000304 · Cited by 213
A cross-sectional, population-based study measuring comorbidity among people living with HIV in Ontario
Kendall, C. E., Wong, J., Taljaard, M., Glazier, R. H., Hogg, W., Younger, J., & Manuel, D. G. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-161 · Cited by 213
Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
Villar, S. S., Pérez-Elı́as, M. J., Dronda, F., Casado, J. L., Moreno, A. M., Royuela, A., Pérez-Molina, J. A., Sainz, T., Navas, E., Hermida, J. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085798 · Cited by 210
Tenofovir Alafenamide Vs. Tenofovir Disoproxil Fumarate in Single Tablet Regimens for Initial HIV-1 Therapy
Sax, P. E., Zolopa, A. R., Brar, I., Elion, R., Ortiz, R., Post, F. A., Wang, H., Callebaut, C., Martin, H., Fordyce, M. W., et al. (2014) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000225 · Cited by 206
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
Chawla, A., Wang, C. E., Patton, C., Murray, M. I., Punekar, Y. S., de Ruiter, A., & Steinhart, C. R. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0201-6 · Cited by 202
Patterns of HIV, TB, and non-communicable disease multi-morbidity in peri-urban South Africa- a cross sectional study
Oni, T., Youngblood, E., Boulle, A., McGrath, N. M., Wilkinson, R. J., & Levitt, N. S. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0750-1 · Cited by 196
HIV as a Cause of Immune Activation and Immunosenescence
Sokoya, T., Steel, H. C., Nieuwoudt, M., & Rossouw, T. M. (2017) · Mediators of Inflammation · doi:10.1155/2017/6825493 · Cited by 198
Chronic illness burden and quality of life in an aging HIV population
Balderson, B. H. K., Grothaus, L. C., Harrison, R. G., McCoy, K., Mahoney, C., & Catz, S. L. (2012) · AIDS Care · doi:10.1080/09540121.2012.712669 · Cited by 192
Chronic kidney disease in the global adult HIV-infected population: A systematic review and meta-analysis
Ekrikpo, U. E., Kengne, A. P., Bello, A. K., Effa, E., Noubiap, J. J., Salako, B. L., Rayner, B. L., Remuzzi, G., & Okpechi, I. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195443 · Cited by 183
The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 – 74 years and more than 75 years
Guaraldi, G., Malagoli, A., Calcagno, A., Mussi, C., Celesia, B. M., Carli, F., Piconi, S., Socio, G. V. D., Cattelan, A. M., Orofino, G., et al. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0789-0 · Cited by 179
Self-citation
Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs
Wilson, E. M. P., & Sereti, I. (2013) · Immunological Reviews · doi:10.1111/imr.12064 · Cited by 176
A frailty index predicts survival and incident multimorbidity independent of markers of HIV disease severity
Guaraldi, G., Brothers, T. D., Zona, S., Stentarelli, C., Carli, F., Malagoli, A., Santoro, A., Menozzi, M., Mussi, C., Mussini, C., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000753 · Cited by 171
Self-citation
Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis
Farahani, M., Mulinder, H., Farahani, A. A., & Marlink, R. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462416632428 · Cited by 168
Psychological, addictive, and health behavior implications of the COVID-19 pandemic
Zvolensky, M. J., Garey, L., Rogers, A. H., Schmidt, N. B., Vujanovic, A. A., Storch, E. A., Buckner, J. D., Paulus, D. J., Alfano, C. A., Smits, J. A. J., et al. (2020) · Behaviour Research and Therapy · doi:10.1016/j.brat.2020.103715 · Cited by 175
Functional Impairment, Disability, and Frailty in Adults Aging with HIV-Infection
Erlandson, K. M., Schrack, J. A., Jankowski, C. M., Brown, T. T., & Campbell, T. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0215-y · Cited by 166
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression
Villar, S. S., Gutiérrez, C., Vallejo, A., Hernández‐Novoa, B., Díaz, L., Abad-Fernández, M., Madrid, N., Dronda, F., Zamora, J., Muñoz‐Fernández, M. Á., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.013 · Cited by 159
Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: A cross-sectional study
Maciel, R. A., Klück, H. M., Durand, M., & Sprinz, E. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.02.009 · Cited by 155
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Tsai, A., Irrinki, A., Kaur, J., Cihlář, T., Kukolj, G., Sloan, D. D., & Murry, J. P. (2017) · Journal of Virology · doi:10.1128/jvi.02166-16 · Cited by 160
Age-related changes in CD8 T cell homeostasis and immunity to infection
Nikolich‐Žugich, J., Li, G., Uhrlaub, J. L., Renkema, K. R., & Smithey, M. J. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.009 · Cited by 155
Systemic Inflammation and the Increased Risk of Inflamm-Aging and Age-Associated Diseases in People Living With HIV on Long Term Suppressive Antiretroviral Therapy
Babu, H., Ambikan, A. T., Gabriel, E. E., Akusjärvi, S. S., Palaniappan, A. N., Sundaraj, V., Mupanni, N. R., Sperk, M., Cheedarla, N., Sridhar, R., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01965 · Cited by 150
Incident fractures in HIV-infected individuals
Shiau, S., Broun, E. C., Arpadi, S. M., & Yin, M. T. (2013) · AIDS · doi:10.1097/qad.0b013e328361d241 · Cited by 147
CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection
Freeman, M. L., Mudd, J. C., Shive, C. L., Younes, S., Panigrahi, S., Sieg, S. F., Lee, S. A., Hunt, P. W., Calabrese, L. H., Gianella, S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ840 · Cited by 151
Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy
Mills, A., Crofoot, G. E., McDonald, C., Shalit, P., Flamm, J., Gathe, J., Scribner, A., Shamblaw, D., Saag, M. S., Cao, H., et al. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000618 · Cited by 140
Premature and accelerated aging: HIV or HAART?
Smith, R. L., de Boer, R., Brul, S., Budovskaya, Y. V., & van der Spek, H. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00328 · Cited by 138
Frailty in People Aging With Human Immunodeficiency Virus (HIV) Infection
Brothers, T. D., Kirkland, S., Guaraldi, G., Falutz, J., Theou, O., Johnston, B. L., & Rockwood, K. (2014) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu258 · Cited by 136
Self-citation
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
Francesco, D. D., Wit, F. W. N. M., Bürkle, A., Oehlke, S., Kootstra, N. A., Winston, A., Franceschi, C., Garagnani, P., Pirazzini, C., Libert, C., et al. (2018) · AIDS · doi:10.1097/qad.0000000000002063 · Cited by 138
Dysregulated B Cell Expression of RANKL and OPG Correlates with Loss of Bone Mineral Density in HIV Infection
Titanji, K., Vunnava, A., Sheth, A. N., Lahiri, C. D., Lennox, J. L., Sanford, S. E., Foster, A., Knežević, A., Easley, K. A., Weitzmann, M. N., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004497 · Cited by 133
Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?
Underwood, J., Robertson, K. R., & Winston, A. (2014) · AIDS · doi:10.1097/qad.0000000000000538 · Cited by 136
Effectiveness of Progressive Resistive Exercise (PRE) in the context of HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol
O’Brien, K. K., Tynan, A., Nixon, S., & Glazier, R. H. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2342-8 · Cited by 134
Achieving the fourth 90
Harris, T. G., Rabkin, M., & El‐Sadr, W. (2018) · AIDS · doi:10.1097/qad.0000000000001870 · Cited by 134
Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort
Pelchen–Matthews, A., Ryom, L., Borges, Á. H., Edwards, S., Duvivier, C., Stephan, C., Sambatakou, H., Maciejewska, K., Portu, J. J., Weber, J. N., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001967 · Cited by 125
Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment
Cassol, E., Misra, V., Dutta, A., Morgello, S., & Gabuzda, D. H. (2014) · AIDS · doi:10.1097/qad.0000000000000303 · Cited by 127
Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us
Buchacz, K. A., Baker, R. K., Palella, F. J., Shaw, L., Patel, P., Lichtenstein, K. A., Chmiel, J. S., Vellozzi, C. J., Debes, R., Henry, K., et al. (2012) · Antiviral Therapy · doi:10.3851/imp2450 · Cited by 126
Self-citation
T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment
AGEhIV Study Group, Jiménez, V. C., Wit, F. W. N. M., Joerink, M., Maurer, I., Harskamp, A. M., Schouten, J., Prins, M., van Leeuwen, E. M. M., Booiman, T., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw146 · Cited by 128
Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study
Duncan, A., Goff, L. M., & Peters, B. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194199 · Cited by 125
Premature Aging and Premature Age-Related Comorbidities in HIV-Infected Patients: Facts and Hypotheses
Capeau, J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir628 · Cited by 125
Aging with HIV
Guaraldi, G., Milić, J., & Mussini, C. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00464-3 · Cited by 118
Self-citation
Immunodominance: A pivotal principle in host response to viral infections
Akram, A., & Inman, R. D. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.01.015 · Cited by 118
HIV and Aging
Erlandson, K. M., & Karris, M. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.04.005 · Cited by 114
Chronic multimorbidity among older adults in rural South Africa
Chang, A. Y., Gómez-Olivé, F. X., Payne, C., Rohr, J. K., Manne‐Goehler, J., Wade, A. N., Wagner, R. G., Montana, L. S., Tollman, S. M., & Salomon, J. A. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001386 · Cited by 114
Aging with HIV vs. HIV Seroconversion at Older Age: A Diverse Population with Distinct Comorbidity Profiles
Guaraldi, G., Zona, S., Brothers, T. D., Carli, F., Stentarelli, C., Dolci, G., Santoro, A., Beghetto, B., Menozzi, M., Mussini, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118531 · Cited by 111
Self-citation
Association of Age With Polypharmacy and Risk of Drug Interactions With Antiretroviral Medications in HIV-Positive Patients
Tseng, A. L.-I., Szadkowski, L., Walmsley, S. L., Salit, I. E., & Raboud, J. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013504075 · Cited by 111
Frailty in HIV-Infected Adults in South Africa
Pathai, S., Gilbert, C. E., Weiss, H. A., Cook, C., Wood, R., Bekker, L., & Lawn, S. D. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318273b631 · Cited by 110
Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events
Monforte, A. D., Reiss, P., Ryom, L., El-Sadr, W. M., Dabis, F., Wit, S. D., Worm, S. W., Law, M. G., Weber, R. K., Kirk, O., et al. (2013) · AIDS · doi:10.1097/qad.0b013e32835b2ef1 · Cited by 108
Antiretrovirals and the kidney in current clinical practice
Yombi, J. C., Pozniak, A., Boffito, M., Jones, R., Khoo, S., Levy, J. B., & Post, F. A. (2014) · AIDS · doi:10.1097/qad.0000000000000103 · Cited by 107
Association Between Short Leukocyte Telomere Length and HIV Infection in a Cohort Study: No Evidence of a Relationship With Antiretroviral Therapy
Zanet, D. L., Thorne, A., Singer, J., Maan, E. J., Sattha, B., Campion, A. L., Soudeyns, H., Pick, N., Murray, M. C. M., Money, D., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu051 · Cited by 106
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
Alrubayyi, A., Gea‐Mallorquí, E., Touizer, E., Hameiri‐Bowen, D., Kopycinski, J. T., Charlton, B. G., Fisher-Pearson, N., Muir, L., Rosa, A., Roustan, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26137-7 · Cited by 107
HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
Heron, S., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00241 · Cited by 104
HIV-Associated Neurocognitive Disorders: A Global Perspective
Saloner, R., & Cysique, L. A. (2017) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617717001102 · Cited by 104
Higher Risk of Abdominal Obesity, Elevated Low-Density Lipoprotein Cholesterol, and Hypertriglyceridemia, but not of Hypertension, in People Living With Human Immunodeficiency Virus (HIV): Results From the Copenhagen Comorbidity in HIV Infection Study
Gelpi, M., Afzal, S., Lundgren, J. D., Ronit, A., Roen, A. O., Mocroft, A., Gerstoft, J., Lebech, A., Lindegaard, B., Kofoed, K. F., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy146 · Cited by 104
HIV-associated neurocognitive disorder
Smail, R. C., & Brew, B. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63849-6.00007-4 · Cited by 106
Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection
Hsu, D. C., & Sereti, I. (2016) · Drugs · doi:10.1007/s40265-016-0546-7 · Cited by 102
HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation
Gootenberg, D. B., Paer, J. M., Luévano, J. M., & Kwon, D. S. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000341 · Cited by 103
Monocyte-Activation Phenotypes Are Associated With Biomarkers of Inflammation and Coagulation in Chronic HIV Infection
Wilson, E. M. P., Singh, A., Hullsiek, K. H., Gibson, D., Henry, W. K., Lichtenstein, K., Önen, N. F., Kojic, E. M., Patel, P., Brooks, J. T., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu275 · Cited by 100
Plasma IL-6 levels are independently associated with atherosclerosis and mortality in HIV-infected individuals on suppressive antiretroviral therapy
Hsu, D. C., Ma, Y. F., Hur, S., Li, D., Rupert, A. W., Scherzer, R., Kalapus, S. C., Deeks, S. G., Sereti, I., & Hsue, P. Y. (2016) · AIDS · doi:10.1097/qad.0000000000001149 · Cited by 101
Enhancing physical function in HIV-infected older adults: A randomized controlled clinical trial.
Shah, K. N., Majeed, Z., Yoruk, Y. B., Yang, H., Hilton, T. N., McMahon, J. M., Hall, W. J., Walck, D., Luque, A. E., & Ryan, R. M. (2016) · Health Psychology · doi:10.1037/hea0000311 · Cited by 100
Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men
Schrack, J. A., Althoff, K. N., Jacobson, L. P., Erlandson, K. M., Jamieson, B. D., Koletar, S. L., Phair, J., Ferrucci, L., Brown, T. T., & Margolick, J. B. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000731 · Cited by 99
No Evidence for Accelerated Aging-Related Brain Pathology in Treated Human Immunodeficiency Virus: Longitudinal Neuroimaging Results From the Comorbidity in Relation to AIDS (COBRA) Project
Cole, J. H., Caan, M. W. A., Underwood, J., Francesco, D. D., van Zoest, R. A., Wit, F. W. N. M., Mutsaerts, H. J. M. M., Leech, R., Geurtsen, G. J., Portegies, P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1124 · Cited by 98
Coronavirus Disease 2019 (COVID-19) Infection Among People With Human Immunodeficiency Virus in New York City: A Population-Level Analysis of Linked Surveillance Data
Braunstein, S., Lazar, R., Wahnich, A., Daskalakis, D., & Blackstock, O. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1793 · Cited by 98
Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management
Ellis, R. J., Marquine, M. J., Kaul, M., Fields, J. A., & Schlachetzki, J. C. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00879-y · Cited by 101
Premature aging and immune senescence in HIV-infected children
Gianesin, K., Noguera‐Julián, A., Zanchetta, M., Bianco, P. D., Petrara, M. R., Freguja, R., Rampon, O., Fortuny, C., Camós, M., Mozzo, E., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001093 · Cited by 104
Non-HIV Comorbid Conditions and Polypharmacy Among People Living with HIV Age 65 or Older Compared with HIV-Negative Individuals Age 65 or Older in the United States: A Retrospective Claims-Based Analysis
Kong, A. M., Pozen, A., Anastos, K., Kelvin, E. A., & Nash, D. (2019) · AIDS Patient Care and STDs · doi:10.1089/apc.2018.0190 · Cited by 97
Decreases in Colonic and Systemic Inflammation in Chronic HIV Infection after IL-7 Administration
Sereti, I., Estes, J. D., Thompson, W. L., Morcock, D. R., Fischl, M. A., Croughs, T., Beq, S., de Micheaux, S. L., Yao, M. D., Ober, A., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003890 · Cited by 102
High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi
Rücker, S. C. M., Tayea, A., Bitilinyu-Bangoh, J., Aza, E. B., Salumu, L., Quiles, I. A., Szumilin, E., Chirwa, Z., Rick, F., & Maman, D. (2017) · AIDS · doi:10.1097/qad.0000000000001700 · Cited by 96
Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort
Pacheco, Y. M., Jarrín, I., Rosado‐Sánchez, I., Campins, A. A., Berenguer, J., Iribarren, J. A., Rivero, M., Muñoz‐Medina, L., Bernal, E., Gutiérrez, F., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.002 · Cited by 94
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection
Guillén, Y., Noguera-Julián, M., Rivera, J., Casadellà, M., Zevin, A. S., Rocafort, M., Parera, M., Rodriguez, C., Arumí, M., Carrillo, J., et al. (2018) · Mucosal Immunology · doi:10.1038/s41385-018-0083-7 · Cited by 95
Reorienting health systems to care for people with HIV beyond viral suppression
Safreed‐Harmon, K., Anderson, J., Muscat, N. A., Behrens, G. M. N., Monforte, A. D., Davidovich, U., del Amo, J., Kall, M. M., Noori, T., Porter, K., et al. (2019) · The Lancet HIV · doi:10.1016/s2352-3018(19)30334-0 · Cited by 93
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial
Esteban-Cantos, A., Rodríguez-Centeno, J., Barrúz, P., Alejos, B., Saiz-Medrano, G., Nevado, J., Martin, A., Gayá, F., Buckley, R. D. M., Bernardino, J. I., et al. (2021) · The Lancet HIV · doi:10.1016/s2352-3018(21)00006-0 · Cited by 94
Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis
Kalligeros, M., Vassilopoulos, A., Shehadeh, F., Vassilopoulos, S., Lazaridou, I., Mylonakis, E. E., Promrat, K., & Wands, J. R. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.01.001 · Cited by 93
Multimorbidity of communicable and non-communicable diseases in low- and middle-income countries: A systematic review
Kaluvu, L. M., Asogwa, O. A., Florensa, A. M., Kyobutungi, C. K., Levitt, N. S., Boateng, D., & Klipstein‐Grobusch, K. (2022) · Journal of Multimorbidity and Comorbidity · doi:10.1177/26335565221112593 · Cited by 91
Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks
Quercia, R., ROBERTS, J. N., Martin-Carpenter, L., & Zala, C. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-014-0266-2 · Cited by 91
Bouncing Back: Resilience and Mastery Among HIV-Positive Older Gay and Bisexual Men
Emlet, C. A., Shiu, C. A., Kim, H., & Fredriksen‐Goldsen, K. I. (2016) · The Gerontologist · doi:10.1093/geront/gnw171 · Cited by 97
The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy
Wang, H., Lu, X., Yang, X., & Xu, N. (2016) · Medicine · doi:10.1097/md.0000000000005146 · Cited by 89
Biological ageing with HIV infection: evaluating the geroscience hypothesis
Montano, M. A., Oursler, K. K., Xu, K., Sun, Y. V., & Marconi, V. C. (2022) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00278-6 · Cited by 94
Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019
Collins, L. F., Palella, F. J., Mehta, C. C., Holloway, J., Stosor, V., Lake, J. E., Brown, T. T., Topper, E. F., Naggie, S., Anastos, K., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.27584 · Cited by 92
Self-citation
HIV-1 Structural Proteins Serve as PAMPs for TLR2 Heterodimers Significantly Increasing Infection and Innate Immune Activation
Henrick, B. M., Yao, X.-D., Rosenthal, K. L., & the INFANT study team (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00426 · Cited by 88
Frailty, Inflammation, and Mortality Among Persons Aging With HIV Infection and Injection Drug Use
Piggott, D. A., Varadhan, R., Mehta, S. H., Brown, T. T., Li, H., Walston, J. D., Leng, S. X., & Kirk, G. D. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv107 · Cited by 91
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Grifoni, A., Alonzi, T., Alter, G., Noonan, D. M., LANDAY, A. L., Albini, A., & Goletti, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1146704 · Cited by 90
HIV-associated cellular senescence: A contributor to accelerated aging
Cohen, J., & Torres, C. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.12.004 · Cited by 93
A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe
Magodoro, I. M., Esterhuizen, T. M., & Chivese, T. (2016) · BMC Research Notes · doi:10.1186/s13104-016-2187-z · Cited by 86
The Impact of Comorbidities, Depression, and Substance Use Problems on Quality of Life Among Older Adults Living With HIV
Millar, B. M., Starks, T. J., Gurung, S., & Parsons, J. T. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1613-5 · Cited by 94
Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm
Cysique, L. A., & Brew, B. J. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0706-5 · Cited by 85
White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy
Su, T., Wit, F. W. N. M., Caan, M. W. A., Schouten, J., Prins, M., Geurtsen, G. J., Cole, J. H., Sharp, D. J., Richard, E., Reneman, L., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001133 · Cited by 84
Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection
Su, T., Schouten, J., Geurtsen, G. J., Wit, F. W. N. M., Stolte, I. G., Prins, M., Portegies, P., Caan, M. W. A., Reiss, P., Majoie, C. B. L. M., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000573 · Cited by 83

Authors: Guaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., & Palella, F.
Affiliations: University of Modena and Reggio Emilia (IT)
Cineca (IT)
University of Bologna (IT)
Northwestern University (US)
ORCID: Guaraldi, G.
Orlando, G.
Zona, S.
Menozzi, M.
Carli, F.
Rossi, E.
Roverato, A.
Venue: Clinical Infectious Diseases
Publisher: Oxford University Press (OUP)
Published: 2011-10-13
Volume: 53
Issue: 11
Pages: 1120-1126
ISSN: 1058-4838 (ISSN-L)
1537-6591
DOI: 10.1093/cid/cir627
OpenAlex: W2135397849
Cited by: 1,331
References: 31
Citations by year: 2026: 63 · 2025: 72 · 2024: 96 · 2023: 84 · 2022: 89 · 2021: 122 · 2020: 119 · 2019: 117 · 2018: 131 · 2017: 100 · 2016: 92 · 2015: 66 · 2014: 79 · 2013: 55 · 2012: 38
FWCI: 65.23
Type: journal article
Language: en
Open access: closed
Locations: Clinical Infectious Diseases (publishedVersion)
PubMed (publishedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion)
Padua Research Archive (University of Padova) (submittedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords: HIV infection, age-related comorbidities, cardiovascular disease, hypertension, diabetes mellitus, bone fractures, renal failure, antiretroviral therapy, risk factors, comorbidity screening
MeSH terms: Adult, Age Factors, Cardiovascular Diseases, Diabetes Mellitus, Female, Humans, Hypertension, Italy, Male, Middle Aged, Risk Factors, HIV Infections, Comorbidity, Prevalence, Case-Control Studies, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Fractures, Bone, Renal Insufficiency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Premature Age-Related Comorbidities Among HIV-Infected Persons Compared with the General Population.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks